Chronic unresolvable stress leads to the development of depression and cardiovascular disease.
New Findings

• What is the central question of this study?
How does chronic stress impact cerebrovascular function and does metabolic syndrome accelerate the cerebrovascular adaptations to stress? What role does exercise training have in preventing cerebrovascular changes to stress and metabolic syndrome?
• What is the main finding and its importance?
Stressful conditions lead to pathological adaptations of the cerebrovasculature via an oxidative nitric oxide pathway, and the presence of metabolic syndrome produces a greater susceptibility to stress-induced cerebrovascular dysfunction. The results also provide insight into the mechanisms that may contribute to the influence of stress and the role of exercise in preventing the negative actions of stress on cerebrovascular function and structure.
2013; Chrapko et al., 2004) . We have previously shown decreased aortic EDD in healthy mice after 8 weeks of unpredictable chronic mild stress (UCMS) (Stanley et al., 2014) , a reliable and sensitive model for studying depressive disorders in rodents (Willner, 2005) . In addition, the normal development of MetS is characterized by chronic lowgrade inflammation and ROS that negatively affect multiple vascular beds, including in the brain Phillips, Sylvester, & Frisbee, 2005) . Thus, there is a general agreement that the endothelium plays a key role in the adverse effects of stress and MetS on the CV system. However, to what extent the cerebral vasculature is affected by psychological stress is not fully known, especially during the simultaneous development of MetS and chronic stress. Thus, the first aim of this study was to determine the impact of concurrent MetS and UCMS on cerebrovascular function and structure.
Regular exercise is an effective therapy for improving depressive symptoms and preventing recurrent depressive episodes and the pathological changes associated with MetS (Donley et al., 2014; Frisbee, Samora, Peterson, & Bryner, 2006) . In the vasculature, exercise has anti-oxidant benefits and is known to improve EDD (Frisbee et al., 2006) . Thus, the second aim of this study was to identify the prophylactic benefits of exercise training on cerebrovascular function in MetS under UCMS. We hypothesize that (1) UCMS impairs cerebrovascular EDD, with a worse response in the obese zucker rat (OZR) vs. lean zucker rat (LZR), and (2) exercise training prevents any further decrease in cerebrovascular EDD during the combination of MetS and UCMS.
MATERIALS AND METHODS
Ethical approval
Zucker rats from Envigo Laboratories (Millstone, NJ, USA) were used to conduct the experiments reported in this article on a protocol approved by the West Virginia University Health Science Center (WVUHSC) Animal Care and Use Committee that meets the NIH guidelines for care and use of laboratory animals and complies with the animal use ethics checklist set forth by Experimental Physiology.
Animals
Male LZR and OZR were housed in the animal care facility at the WVUHSC and fed standard chow/drinking water ab libitum. Animals undergoing exercise training and/or chronic stress treatment were handled and inspected daily, with regular supervision of the veterinary support staff. At 8-9 weeks of age, LZR and OZR were divided (8 per strain per group; total of 64 rats) into four groups: (1) age-matched controls, (2) UCMS, (3) treadmill exercise (Ex), or (4) UCMS with treadmill exercise (UCMS+Ex).
Control group
All control animals were singly housed and remained in their home cages throughout the 8-week period. Animals were exposed to daily handling to normalize for the interaction with the staff.
UCMS protocol
Previous investigators developed the UCMS model to induce depression-like behaviours in rodents (Mineur, Prasol, Belzung, & Crusio, 2003) . The UCMS model is considered to be the most appropriate rodent model for human clinical depression, based on its ability to reproduce the development of many human clinical depressive symptoms, including anhedonia and learned helplessness (Willner, 2005) . All rats were singly housed. Rats were exposed to the following mild environmental stressors in randomly chosen sequences for 8 h each day, 5 days week −1 , over the course of 8 weeks:
1. damp bedding -296 ml of water was added to each standard cage 2. bath -all bedding was removed and ∼12.7 mm of water was added to the empty cage. Water temperature was room temperature,
3. cage tilt -the cage was tilted to 45 deg without bedding 4. social stress -each rat was switched into the cage of a neighbouring rat 5. no bedding 6. alternation of light-dark cycles -turning lights off/on in random increments for a scheduled period
Exercise training group
LZR and OZR underwent 8 weeks of treadmill running. Animals ran 5 days week −1 on a motor-driven treadmill set at a 5% grade. During the first week, animals were acclimatized to the treadmill by running for 20 min, which was then increased by 10 min day −1 until a sustainable duration of 60 min daily was achieved. A maximum speed test was performed on each animal and target running speed was set for 60-70% of that maximum, which represented 10-12 and 18-20 m min −1 for OZR and LZR, respectively, at a 5% incline. After the acclimatization week, the first 15 min of the total 60 min consisted of a gradual increase until target running speed was reached. Rats ran at this speed for the remaining 45 min. There was a 48 h wash-out period between the last Ex bout and the terminal surgery at the end of the 8-week treatment.
UCMS+Ex group
Following the above protocols for UCMS and exercise training, LZR and OZR underwent 8 weeks of treadmill running concurrently with UCMS. Note that on each day exercise training was performed first followed by the UCMS protocol.
Coat status
The condition of the animal's coat was evaluated throughout the duration of the study. Each week, rats were weighed and inspected for grooming habits. The total cumulative score was computed by giving an individual score of 0 (clean) or 1 (dirty) to eight body parts (head, neck, back, stomach, tail, forelimbs, hindlimbs, genitals) . Within LZR and OZR groups, the individual assessing the animal's coat score was blinded to the group allocation.
Collection of middle cerebral arteries
After the 8-week treatment period, rats were deeply anaesthetized by IP injection of sodium pentobarbital (50 mg kg −1 ) and a carotid artery was cannulated for determination of mean arterial pressure. Animals were then euthanized via severing of the diaphragm and subsequent removal of aorta and skull. The brain was removed from the skull and placed in cold physiological salt solution (PSS; 4 • C). Both middle cerebral arteries (MCA), which supply ∼50% of the cerebral blood flow (Harper, Bohlen, & Rubin, 1984) , were dissected from their origin at the circle of Willis and placed into an isolated microvessel chamber filled with PSS. Each MCA was subsequently doubly cannulated within a heated chamber (37 • C) that allowed the lumen and exterior of the vessel to be perfused and superfused, respectively, with PSS from separate reservoirs. The PSS was equilibrated with a 21% O 2 -5% CO 2 -74% N 2 gas mixture and had the following composition (mM): 119 NaCl, 4.7 KCl, 1.17 MgSO 4 , 1.6 CaCl 2 , 1.18 NaH 2 PO 4 , 24 NaHCO 3 , 0.026 EDTA and 5.5 glucose. Any side branches were ligated using a single strand teased from a 6-0 suture. MCA diameter was measured using television microscopy and an on-screen video micrometer.
Measurements of vascular reactivity in isolated MCA
Following cannulation, MCAs were extended to their in situ length and were equilibrated at 80% of the animal's mean arterial pressure to approximate in vivo perfusion pressure. Any vessel that did not demonstrate significant active tone (>25% for all groups) at the equilibration pressure was discarded. Active tone at the equilibration pressure was calculated as (ΔD/D max ) × 100, where ΔD is the diameter increase from rest in response to Ca 2+ -free PSS and D max is the maximum diameter measured at the equilibration pressure in Ca 2+ -free PSS. 
Determination of cerebral microvessel density
Cerebral microvessel and capillary density was evaluated by fluorescence immunohistochemistry using purified rat anti-mouse ImageJ (NIH). A total of six regions of interest (3 in cortex and 3 in striatum) in the MCA territory were evaluated and mean values from each animal were used for further analysis as described previously (Zechariah et al., 2013) .
Measurement of vascular NO bioavailability
Cerebral NO production was measured by fluorescence microscopy with the NO-specific dye 4-amino-5-methylamino-2 ′ , 7 ′ -difluorofluorescein diacetate (DAF-FM-DA; Thermo Fisher Scientific) according to manufacturer's instructions (Rathel, Leikert, Vollmar, & Dirsch, 2003 
Dihydroethidium staining for ROS
Dihydroethidium ( the mean of the three images was used for each animal.
Plasma clinical markers
Fasting blood was drawn intravenously from anaesthetized rats into 
Circulating cortisol
Corticosterone is a glucocorticoid produced by the adrenal cortex in response to ACTH (corticotropic hormone) and is the precursor to aldosterone. This is the main glucocorticoid in rodents as cortisol is in humans. The production of glucocorticoids is increased by stress. Using a commercially available ELISA Kit (Cayman Chemical, cat. no. 501320) serum corticosterone levels were measured in duplicate accordingly to the manufacturer's instructions.
Data and statistical analyses
All calculations of passive arteriolar wall mechanics (used as indicators of structural alterations to the individual microvessel) are based on those used previously (Baumbach & Hajdu, 1993) , with minor modification. Vessel wall thickness was calculated as:
where WT represents wall thickness ( m) and OD and ID represent arteriolar outer and inner diameter, respectively ( m).
For the calculation of circumferential stress, intraluminal pressure (P IL ) was converted from mmHg to Nm −2 , where 1 mmHg = 1.334 × 10 2 N m −2 . Circumferential stress ( ) was then calculated as:
Circumferential strain ( ) was calculated as: an interaction term (strain-by-group), and a Tukey post hoc test was performed to determine differences between groups, as appropriate.
DHE and DAF-FM were examined using the Kruskal-Wallis test;
within-group comparisons were examined using the Mann-Whitney test. The -slope of the stress-strain relationships between groups were compared with a one-way ANOVA with Tukey post hoc test, as appropriate. In all cases, P ≤ 0.05 was taken to reflect statistical significance. Table 1 presents the characteristics of the animal groups. At the completion of the study, a small decrease in body mass was evident in all experimental groups compared to controls, with no significant differences between UCMS, Ex or UCMS+Ex groups. No differences were noted between experimental groups (within LZR and OZR) for MAP and TG. A significant group-by-strain interaction was identified for TC, indicating that the response of TC differed between LZR and OZRs (higher in OZRs) and between intervention groups (lower with exercise in OZRs). Glucose and insulin levels were higher (27% and 75%, respectively, P < 0.05) in the LZR UCMS vs. LZR controls, whereas
RESULTS
Ex and UCMS+Ex did not significantly affect glucose and insulin levels (Table 1) . In OZR UCMS, both glucose and insulin levels were higher (25% and 18%, respectively, P < 0.05) vs. OZR control. The OZR Ex group had a lower glucose and insulin levels vs. OZR control (P < 0.05),
whereas UCMS+Ex prevented the increase in glucose and insulin levels noted in the OZR UCMS group (Table 1) .
Serum levels of corticosterone were significantly increased in the UCMS, Ex and UCMS+Ex groups compared to LZR and OZR controls (Table 1) . Similarly, throughout the 8-week UCMS protocol, the coat status in rats undergoing UCMS was consistently poorer compared with control animals. However, an increase in coat score was also noted in the LZR UCMS+Ex, OZR Ex and UCMS+Ex groups compared to their respective controls (Table 1) . We also measured adrenal weights and noted that LZR and OZR UCMS groups had a significant (P < 0.05) increase in adrenal weights compared to LZR (16.8 ± 1.2 vs. 25.2 ± 2.9 g) and OZR (27.2 ± 2.2 vs. 32.7 ± 3.9 g) controls. Unfortunately, the adrenal weights were not collected for the Ex groups; however, in the LZR UCMS+Ex group, the adrenal weights did not differ from LZR control weights (21.4 ± 1.9 vs. 16.8 ± 1.2 g). In contrast, the adrenal weights in the OZR UCMS+Ex group remained elevated compared to the OZR control (32.0 ± 2.9 vs. 27.2 ± 2.2 g, P < 0.05) and was similar to the OZR UCMS group (32.0 ± 2.9 vs.
32.7 ± 3.9 g). These data support the corticosterone and coat score data suggesting that UCMS induced significant stress.
The average work performed during the treadmill running was slightly lower (P < 0.05) in the LZR UCMS+Ex (330 ± 49 J) vs. LZR Ex group (402 ± 39 J), and slightly higher (P < 0.05) in the OZR UCMS+Ex (502 ± 56 J) vs. OZR UCMS group (421 ± 49 J).
MCA reactivity 3.1.1 Endothelium-dependent dilatation
The incubation with L-NAME eliminated ∼73% of vasodilatation (P < 0.05) ( Table 2 ). The MCA dilator response to ACh did not differ between LZR control and Ex groups ( Figure 1a ). In contrast, when Ex was combined with UCMS, the LZR MCA dilator response (10 −5 M) was 31% higher (P < 0.05) compared to LZR UCMS, and similar to LZR controls ( Figure 1a ). As before, acute incubation with L-NAME blunted most of the dilatory response to ACh (P < 0.05), and this response did not differ in Ex or UCMS+Ex compared to LZR controls (Table 2) . Similarly, TEMPOL incubation had no additional benefit on ACh dilatation in the LZR Ex or LZR UCMS+Ex group.
In OZR, the MCA dilator response to ACh was 35% lower (P < 0.05) compared to OZR controls (Figure 1 ), and TEMPOL incubation restored MCA dilatation to OZR control levels, while L-NAME incubation completely eliminated all MCA reactivity to ACh (P < 0.05) ( Insulin plasma (ng ml −1 ) 1.2 ± 0.5 2.1 ± 1.0 1.4 ± 0.7 1.8 ± 1.0 6.6 ± 2.7 7.8 ± 3.7* 4.6 ± 2.4* 6.2 ± 2.4 TG (mg dl −1 ) 2 5 ± 7 5 4± 39 31 ± 7 3 6± 7 124 ± 20 114 ± 34 82 ± 37 103 ± 39 TC (mg dl −1 ) † 86 ± 10 87 ± 12 95 ± 15 88 ± 5 256 ± 64 213 ± 42 181 ± 20* 187 ± 27* Corticosterone (ng ml −1 ) 6.97 ± 0.4 8.78 ± 1.3* 9.44 ± 2.6 10.67 ± 3.6* 13.82 ± 1.4 17.30 ± 3.6* 10.60 ± 2.4* 15.78 ± 3.6 § Coat scores (AU) 0.8 ± 0.5 1.8 ± 0.5* 0.9 ± 0.5 2.0 ± 0.7* 2.7 ± 0.5 5.1 ± 0.5* 3.4 ± 0.7 4.8 ± 0.5* , § Data expressed as means ± SD; n = 6-8/group. * P < 0.05 vs. con group within the same strain (i.e. LZR or OZR). ‡ P < 0.05 vs. UCMS group within strain. § P < 0.05 vs. Ex group. † P < 0.05 signifies group-by-strain interaction, i.e. a significant group-by-strain interaction was identified for TC, indicating that the response of TC differed between LZR and OZRs (higher in OZRs) and between intervention groups (lower with exercise in OZRs). MAP, mean arterial pressure; TC, total cholesterol; TG, triglycerides. . Data presented as means ± SD; n = 6-8/group. *P < 0.05 vs. control rats within strain), ‡ P < 0.05 vs. UCMS group (within strain), § P < 0.05 vs. Ex group (within strain), # P < 0.05 vs. UCMS+Ex group (within strain). See text for details TA B L E 2 The change in middle cerebral artery maximal dilatation to ACh in the presence of TEMPOL or L-NAME
MCA endothelium-dependent dilatation No treatment ( m) L-NAME ( m) TEMPOL ( m)
LZR Con 24.0 ± 2.9 6.0 ± 2.9 ‡ 27.5 ± 5.9 ¶ LZR UCMS 17.3 ± 3.7 5.7 ± 2.9 ‡ 21.6 ± 3.9 ‡, ¶
LZR Ex
OZR UCMS 8.1 ± 6.1 −1.3 ± 5.6 ‡ 13.9 ± 4.9 ‡, ¶ OZR Ex 22.4 ± 6.1 11.0 ± 3.2 ‡ 26.6 ± 3.7 ‡, ¶ OZR UCMS+Ex 15.8 ± 3.7 −1.4 ± 9.6 ‡ 16.8 ± 2.7 ¶ Data are expressed as means ± SD; n = 5-8/group. MCA dilatation to maximal dose of ACh (10 −6 M). ‡ P < 0.05 vs. no-treatment within group. ¶ P < 0.05 vs. L-NAME treatment within group.
(10 −5 M) 2-fold (P < 0.05) vs. OZR controls. Further, the OZR UCMS+Ex group had a 95% higher (P < 0.05) MCA dilatation (10 −5 M) compared
to OZR UCMS and a slightly higher (27%, NS) MCA dilatation compared to OZR controls (see Figure 3b) . In OZR, acute incubation with L-NAME reduced MCA dilatation to ACh (P < 0.05), but a significant dilator response was still evident on OZR Ex suggesting other non-NO-dependent pathways were upregulated (Table 2) . In OZR UCMS+Ex, L-NAME completely removed the MCA dilatation to ACh (P < 0.05). TEMPOL incubation had little to no additional benefit on ACh dilatation in the OZR Ex or OZR UCMS+Ex group. Figure 1c and d presents the endothelium-independent change in MCA reactivity to SNP. In LZR, the MCA dilatation to SNP was not affected by UCMS, Ex or the combination of UCMS+Ex.
Endothelium-independent dilatation
In OZR, a 20% lower (P < 0.05) MCA dilatation to SNP (10 −5 M) was noted in UCMS vs. OZR controls (Figure 1 ). In addition, in OZR, Ex improved MCA dilatation to SNP by 29%, vs. OZR controls (P < 0.05),
and UCMS+Ex prevented the reduction in MCA dilatation to SNP in the OZR UCMS group (P < 0.05) (Figure 1d ).
Constrictor responses
The response of the MCA to 5-HT, a potent vasoconstrictor, is presented in Figure 2 . In LZR, UCMS increased the MCA constriction to 5-HT by 24% (P < 0.05) compared to LZR controls. Pretreatment of (Table 3) suggesting that the UCMS group had reduced NO bioavailability. The MCA constriction response to 5-HT in LZR Ex was similar to that of LZR controls (Table 3) ; however, Ex prevented the increased MCA constrictor response to 5-HT in the LZR UCMS+Ex vs. LZR UCMS groups. Pre-incubating the MCA with either L-NAME or TEMPOL did not affect the MCA response to 5-HT in any LZR group.
In OZR, the MCA constriction response was 16% lower (P < 0.05) in UCMS vs. OZR controls (Figure 2b ). In OZR controls and UCMS, pretreatment of the MCA with L-NAME or TMEPOL had no effect on the response to 5-HT (Table 3) . Further, the MCA constrictor response to 5-HT was slightly, albeit not significantly, lower in OZR Ex vs. OZR controls (Figure 2b ). The MCA constrictor response was similar between UCMS+Ex vs. UCMS OZR groups (Figure 2b ). The only significant difference was noted between Ex vs. UCMS+Ex groups, 
TA B L E 4 Middle cerebral artery remodelling
MCA wall diameters, stiffness and vessel density
We next examined the extent to which UCMS affected the stiffness and remodelling of the MCA and MVD. In LZR, there were no significant differences in the MCA stress-strain relationship (or -slope), diameters and WT between LZR controls and UCMS (Table 4 and Figure 3a ). However, MVD (cortex and striatum) was reduced (P < 0.05) in LZR UCMS vs. LZR controls (Figure 4 ). In LZR, MCA wall diameters, WT and stiffness did not differ between UCMS, Ex and UCMS+Ex groups (Table 4 and Figure 3a) . Importantly, cortical MVD in the LZR was 25% higher (P < 0.05) in the UCMS+Ex vs. UCMS group, but no differences in MVD were noted in the striatum (P = 0.12). When compared to the Ex alone group, MVD (both cortex and striatum) was lower (P < 0.05) in the LZR UCMS+Ex group (Figure 4 ).
In OZR, UCMS resulted in a slight decrease in MCA outer diameter, a reduced WT (P < 0.05), and reduced wall to lumen ratio (P = 0.08) compared to OZR controls (Table 4) 
F I G U R E 4
The effects of stress and exercise on cerebral microvessel density. Cerebral microvessel density in the cortex (a) and striatum (b) was measured in LZR (open bars) and OZRs (filled bars) under control, UCMS, Ex or UCMS+Ex conditions. Data presented as means ± SD; n = 5-6/group. *P < 0.05 vs. control (within strain), ‡ P < 0.05 vs. UCMS group (within strain), § P < 0.05 vs. Ex group (within strain). See text for details control and OZR UCMS (Table 4) . Due to the similar general increase in inner and outer MCA wall diameters, no differences were noted in WT or wall to lumen ratio in Ex or UCMS+Ex vs. OZR control or OZR UCMS (Table 4) . Importantly, Ex in the OZR group shifted the stress-strain relationship to the right (reduced stiffness) compared to OZR control with a reduced -slope (P < 0.05). Further, UCMS+Ex prevented the leftward shift in the stress-strain relationship noted in the OZR UCMS group (Figure 3b ). Similar beneficial effects were noted with MVD. MVD (both cortex and striatum) was higher (P < 0.05) in the OZR Ex vs. control group (Figure 4) . Further, the combination of UCMS+Ex resulted in a higher (P < 0.05) MVD (both cortex and striatum) compared to the OZR UCMS group (Figure 4) . No differences were noted in MVD between OZR Ex and OZR UCMS+Ex groups in either cortex or striatum.
Oxidative stress and NO
Because both MCAs were used for ex vivo reactivity data, we iso- 
F I G U R E 6
The effects of stress and exercise on nitric oxide production. 
Role of UCMS
Stressful circumstances activate the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system to release stress hormones. Chronic exposure to stressful conditions also leads to an allostatic overload, resulting in maladaptive responses of various organs and, as our data would suggest, initiates patho-physiological adaptations of the cerebrovasculature. Indeed, corticosterone levels were elevated in the UCMS groups, coupled with an increase in adrenal weights and reduced grooming response, suggesting significant activation of the HPA axis. We have previously shown, in a lean healthy mouse model, that UCMS leads to a pre-atherosclerotic phenotype in the aorta (Stanley et al., 2014) . We now show that chronic stress in a healthy lean rat leads to significant impairment in MCA EDD and an exaggerated MCA constriction response, coupled with an increase in ROS and reduced NO bioavailability in the cerebral vessels. Interestingly, these cerebrovascular adaptions to UCMS in LZR reflect what we see in an OZR control (without UCMS) i.e. 8 weeks of UCMS transformed the LZR cerebrovasculature to one with similar dysfunction to that seen in the OZR. However, as seen in the OZR UCMS group, stress combined with development of MetS resulted in additional pathological cerebrovascular adaptations. Of note, the lack of change in blood pressure in the UCMS groups would suggest that other mechanisms were involved in the development of the cerebrovascular dysfunction noted with UCMS.
The blunted EDD in the MCA with UCMS groups likely reflects the ROS impairment of NO bioavailability in the cerebral vessels as shown by the increased DHE and reduced DAF fluorescence signal in both LZR and OZR UCMS vessels. Whereas acute treatment of the MCA with L-NAME further reduced EDD in LZR UCMS, some dilatory response to ACh remained (i.e. prostanoid dilators and endothelium-derived hyperpolarization factors) (Figure 1c ). In contrast, acute treatment of the MCA with L-NAME wiped out all EDD in the OZR UCMS group (Figure 1d ), suggesting that in addition to a loss of NO bioavailability, the ancillary dilatory pathways were also affected. Indeed, pro-oxidative conditions, such as UCMS, can alter the balance between constricting and dilating metabolites, such as shifting arachidonic acid metabolism by COX to the production of vasoconstricting metabolites (e.g. thromboxane) that can compete against the vasodilatory stimulus from NO, prostacyclin or other vasodilators (Isingrini et al., 2011) . We have previously shown such a response in the mouse aorta after UCMS (Stanley et al., 2014) . There is also ample evidence supporting a role for cortisol in the UCMS-induced EDD dysfunction. Increased cortisol levels have also been shown to decrease NO synthesis or bioavailability by inhibiting endothelial NO synthase directly (Liu, Mladinov, Pietrusz, Usa, & Liang, 2009 ) and indirectly via the cortisol actions on increasing ROS production (Iuchi et al., 2003) .
It is also interesting to note that unlike the LZR UCMS group, UCMS in OZR negatively altered smooth muscle dilatation (Figure 2b ). between OZR controls and OZR UCMS. However, the extent to which wall distensibility contributed to impaired reactivity is difficult to assess owing to the concurrent impairment of the mechanisms of dilator reactivity (i.e. loss of NO bioavailability). Hypertension is known to decrease the MCA inner diameter (Baumbach & Heistad, 1989; Izzard, Horton, Heerkens, Shaw, & Heagerty, 2006) , but unlike our study, hypertension also increases wall thickness to normalize the increased wall stress and protect the downstream arterioles from the increased pressure (Baumbach & Heistad, 1989) . In our study, the lack of change in wall thickness with UCMS likely reflects the minor blood pressure changes. The hypotrophic remodelling noted in the OZR UCMS group might reflect chronic decreases in blood flow, which is in agreement with previous studies in resistance arteries (Buus et al., 2001; Pourageaud & De Mey, 1997) . Vessel diameter and functional hyperaemic responses play a role in maintaining adequate blood flow to each region of the brain, and must be able to respond accordingly to accommodate increases in flow during periods of higher neural activity. Impairments in any or all of these processes may have significant impact on neuronal metabolism and activity.
The effect of chronic stress on cerebral MVD has not been thoroughly studied. The present study showed that CD31 + cells were decreased with UCMS in LZR and OZR. Our previous research into the physiological mechanisms contributing to microvascular rarefaction in the brain and skeletal muscle has implicated the balance between oxidant stress and endothelial function (e.g. NO bioavailability, altered arachidonic acid metabolism) as a key contributor to the progression and severity of microvascular rarefaction, with the degree of loss in NO bioavailability reflecting the severity of the rarefaction that followed . As such the reduction in NO bioavailability with a corresponding higher ROS with UCMS might have directly contributed to the loss in cerebral MVD. This reduction in the cerebral MVD with UCMS could have clinical consequences. Microvascular rarefaction affects spatial haemodynamics and induces a non-uniform blood flow distribution, and it has been implicated in reducing the capillary transport of small solutes (Henrich, Romen, Heimgartner, Hartung, & Baumer, 1988) . Such pathological adaptations could also damage cerebral auto-regulation and cerebral blood flow reserve, favouring the occurrence of cognitive impairment and ischaemic stroke (Brown et al., 2007; van Dijk et al., 2008) .
Role of exercise
For interventions aimed at treating or alleviating the effects of chronic stress on the cerebrovasculature to be successful, it is essential to understand the pathways that might explain the association between psycho-social stress and CVD. Given that the proposed pathways by which chronic stress has its effects are extensive, we deployed an intervention that is known to have extensive actions on multiple pathways. It is well known that exercise has been shown to have beneficial effects on CV function (Sattelmair et al., 2011) and mental health outcomes (Herring, O'Connor, & Dishman, 2010) . Evidence also suggests that physiological adaptations to regular exercise lead not only to improved physiological control during exercise but also in response to psychological stressors, reflecting a 'cross-stressor adaptation' (Sothmann et al., 1996) .
Exercise training did not improve MCA function or MVD in healthy lean rats; this was likely due to the optimal functional status of the MCA (i.e. low ROS and good NO bioavailability). In contrast, exercise in the OZR group was able to prevent MCA dysfunction and MCA stiffness, and maintain MVD at levels similar to LZR controls. These data show that exercise training can help to preserve MCA endothelial function with MetS possibly by limiting the development of ROS. Importantly, when UCMS was concurrent with exercise training, the negative actions of UCMS on MCA function, stiffness and microvascular rarefaction were prevented. Thus, our data support the idea that the benefits of exercise reach beyond the vascular beds of just the exercising muscles, in this case to maintain vascular health in the brain.
The mechanisms by which regular exercise induces beneficial effects in the cerebral vasculature are not fully known. But it seems likely that the repeated exposure to increases in blood flow and shear stress in specific regions of the brain during exercise will play a role (Endres et al., 2003) . Exercise training has been shown to stimulate brain activity, increase cerebral blood flow (van Hall et al., 2009) , induce eNOS expression, reduce ROS production and upregulate angiogenic proteins in the cerebral arterioles with a corresponding improvement in cognitive function (Cechetti et al., 2012; Mayhan, Arrick, Patel, & Sun, 2011; Mayhan, Sun, Mayhan, & Patel, 2004; van Praag, Christie, Sejnowski, & Gage, 1999) . In our study, exercise may have limited the deleterious effects of UCMS on the cerebrovasculature, in part, by increasing NO bioavailability and reducing ROS ( Figure 5 ). This improved NO bioavailability was also supported by the L-NAME data whereby in the OZR UCMS+Ex group, L-NAME completely removed all EDD to ACh suggesting that the increased EDD to ACh was reflective of an increase in NO rather than the additional dilator pathways. However, the increased NO in the LZR UCMS+Ex group compared to LZR UCMS seemed to occur without major changes in ROS. There are two possibilities for this: first, the bioavailability of NO in the LZR Ex group may have exceeded the levels noted in the LZR UCMS+Ex group, and thus despite elevated ROS, NO production exceeded what was being converted to peroxynitrite. Unfortunately, we do not have the NO levels in the LZR exercise group to verify this scenario. Second, exercise might prevent eNOS uncoupling. In an ageing model, exercise was shown to increase tetrahydrobiopterin (an important co-factor for NO production) levels (Sindler, Delp, Reyes, Wu, & Muller-Delp, 2009 ).
Furthermore, exercise may prevent the co-localization of NADPH oxidase with eNOS by caveolin-1, known to occur upon stimulation with stress hormones. In this scenario, ROS production could stay elevated but compartmentalized away from eNOS allowing eNOS to remain coupled and reduce the interaction of NO and superoxide, thus improving EDD. Irrespective of the mechanism, our data support numerous previous studies demonstrating that a chronic exercise regimen is effective in increasing vascular NO bioavailability (Durrant et al., 2009; Frisbee et al., 2006) .
In addition to the improved EDD, exercise improved endothelial dilatation to SNP in OZR. However, this beneficial response was lost when exercise was combined with UCMS in OZR. To what extent chronic exercise training affects the secondary messengers and receptors involved in smooth muscle relaxation is relatively unknown.
In adult male rats, 6 weeks of exercise training increased brain tissue levels of soluble guanylyl cyclase, a key enzyme and receptor in the NO-soluble guanylate cyclase-cGMP pathway (Chalimoniuk, Chrapusta, Lukacova, & Langfort, 2015) . It is possible that exercise training was able to increase the sensitivity of the MCA smooth muscle to secondary messengers, restoring SNP dilatation in the OZRs.
Our study also demonstrated that exercise shifted the stressstrain relationship to the right with a reduced -slope in the OZR Ex group, suggesting reduced MCA stiffness in the OZR with exercise. Importantly, the combination of UCMS+Ex, although not as effective as Ex alone, prevented the leftward shift in the stress-strain relationship noted in OZR UCMS. Exercise training is well known to improve arterial stiffness of various arterial beds (Donley et al., 2014; Laughlin, Bowles, & Duncker, 2012) . However, there is little information on how exercise affects cerebrovascular stiffness and remodelling. In the small mesenteric and coronary arteries, exercise training improved arterial stiffness in hypertensive rats (Roque et al., 2013) . Collagen and elastin and their organization at the internal elastic lamina are central elements in arterial stiffness (Briones et al., 2003) . Thus, the reduced MCA stiffness with exercise may reflect a normalization of collagen disposition as previously shown (Roque et al., 2013) . However, the reduced MCA stiffness with exercise may also be due to a reduction in ROS, which can increase arterial stiffness via its effects on the inactivation of NO, regulation of cell growth and differentiation, modulation of synthesis and degradation of extracellular matrix proteins, and activation of many kinases (Lee & Griendling, 2008) . Indeed, a reduction in ROS production correlates with the normalization of the increased arterial stiffness in the mesenteric artery (Briones et al., 2009 ) and MCA , likely via improved NO bioavailability. Thus, the improved NO-ROS environment in the cerebrovasculature could play an important role in maintaining cerebral MVD with exercise training, especially when combined with UCMS. We have previously shown that interventions aimed at improving vascular NO bioavailability and reducing oxidant stress (e.g. TEMPOL, captopril, metformin and rosiglitazone) were the most effective at blunting the severity of the cortical microvascular rarefaction . Thus, our current data further support the argument that loss of NO bioavailability and increased ROS are driving the pathological changes in the MVD and the MCA morphological changes noted above in the OZR.
Exercise can affect both the adrenergic and corticosteroid systems involved in stress response, and thus it is not surprising that other studies have demonstrated an increase in stress hormones with exercise, especially forced treadmill running (Svensson, Lexell, & Deierborg, 2015) . Indeed, forced running exercise in rodents can lead to anxiety and increase the levels of stress hormones (Leasure & Jones, 2008; Svensson et al., 2016) . The current study also showed higher levels of corticosterone in the LZR and OZR, albeit significance was only obtained in the OZR. Despite the elevated stress levels in the exercise groups, beneficial effects on the cerebrovasculature were evident especially in the OZR. However, the overall positive effect of exercise in experimental models could potentially be masked by the stress response. Given the sedentary nature of the OZR, it was important to deploy a forced treadmill running protocol as opposed to voluntary wheel running, which in itself can cause stress, to ensure all rats were subjected to an exercise stimulus.
Clinical significance
Early recognition of stress/depression-associated vascular impairments, especially in individuals with MetS, may provide a valuable time window to treat individuals to protect their cerebral vasculature.
The current study deployed the Ex protocol each day prior to the UCMS protocol to limit the likelihood of poor Ex training post-UCMS.
Further, the Ex protocol was deployed during rather than after the development of stress and depression. To what extent the positive changes in cerebrovascular function would have been affected if the UCMS exposure was performed before the Ex protocol, or whether exercise training began after the development of chronic stress and depression is beyond the scope of the present study. However, it certainly has clinical relevance given that over 350 million people worldwide suffer from depressive disorders. Numerous studies have shown exercise to be beneficial in improving depressive symptoms in already depressed individuals (Dunn, Trivedi, & O'Neal, 2001; Mather et al., 2002) (McNeil, LeBlanc, & Joyner, 1991; Nabkasorn et al., 2006) .
In addition, it has also been shown that reducing physical activity leads to increased symptoms of depression (Lampinen, Heikkinen, & Ruoppila, 2000) and that depressive symptoms decrease when physical activity is resumed (Farmer et al., 1988) . These data would suggest that as long as the individual can or wishes to exercise, improvements in depressive symptoms will occur. Thus, we speculate and expect to see some improvements in cerebrovascular if exercise was performed after the UCMS or after the development of depression in our rodents. However, individuals with depression who are unwilling or unable to exercise daily could be prophylactically treated with drugs that have pleiotropic benefits such as atorvastatin Chantler et al., 2015; Pretnar-Oblak, Sabovic, Sebestjen, Pogacnik, & Zaletel, 2006) , which may limit the deleterious impact of chronic stress on neurological and cerebrovascular health in individuals with MetS, potentially conferring the anti-depressant and vasculo-protective benefits of exercise.
Limitations
A limitation of the study reflects the MCA remodelling that was determined ex vivo during the passive mechanics experiments. Future research should directly examine the compositional changes (collagen, elastin, etc.) in the cerebral vessels to gain further insights into the role of UCMS and Ex on MCA remodelling. Further, due to the use of the MCAs for ex vivo pressure myography, we needed to examine other cranial arteries (PCA and basilar) for the DHE and DAF-FM procedures. We also realize the limitation associated with measuring tissue superoxide levels by DHE. While our excitation/emission gating does detect signals produced by oxidation products that may originate from reactions independent of superoxides, the spectral overlap does not exclude considerable contributions from 2-hydroxyethidium, the superoxide-specific oxidation product of hydroethidine (Zielonka & Kalyanaraman, 2010) . With this in mind, and considering our data demonstrate an inverse relationship between DHE-detectable superoxides and NO, we believe these data strongly support the hypothesis that the rapid, diffusion-controlled reaction between NO and superoxides forms peroxynitrite. Another limitation of the study is that we did not collect data on muscle citrate synthase activity to determine improvements in exercise capacity. However, we have previously deployed a similar exercise protocol that resulted in significant improvements in muscle citrate synthase activity (30-50%) in LZR and OZR (Frisbee et al., 2006 ), but we are unable to determine whether the Ex vs. UCMS+Ex groups resulted in a similar improvement in exercise capacity. A limitation to the exercise training was that we exercised the rats at approximately the same relative intensity (60-70% max running speed), which resulted in slight differences in absolute work performed, whereby the average workload performed during each treadmill session was similar between LZR and OZR Ex groups, but lower in the LZR UCMS+Ex group (P < 0.05) compared with the LZR and OZR Ex groups, and higher in the OZR UCMS+Ex group (P < 0.05) compared to the other groups. As such, the differences in absolute work performed may have affected the results of the study; however, the UCMS+Ex groups demonstrated important cerebral vascular improvements irrespective of differences in absolute workload performed. Other limitations include the single blood pressure measurement during the terminal procedures and that our data were collected in only male rats. Our collaborators have previously shown that compared to healthy males, healthy female mice were more susceptible to chronic stress in terms of the severity of depressive behaviours, but that the subsequent development of vasculopathy was blunted (Stanley et al., 2014) . Thus, future research should examine how UCMS and Ex affect LZR and OZR female rats, and blood pressure should be tracked during the development of stress and depression.
Conclusion
Our data show that chronic exposure to stressful conditions leads to pathological adaptations of the cerebrovasculature via an ROS-NO pathway. Further, we have shown that MetS (OZR) has an additive effect on the cerebral vascular dysfunction noted with UCMS compared to lean healthy rats. Our results also provide initial insight into the mechanisms that may contribute to the influence of UCMS and the role of exercise on preventing the negative actions of UCMS on cerebrovascular function and structure.
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